The Role of Polymorphic Donor Peptides in Allograft Recognition and Rejection
- 1 December 1996
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 154 (1), 21-43
- https://doi.org/10.1111/j.1600-065x.1996.tb00928.x
Abstract
No abstract availableThis publication has 61 references indexed in Scilit:
- Indirect Recognition of Donor MHC Class II Antigens in Human TransplantationClinical Immunology and Immunopathology, 1996
- THE INDIRECT PATHWAY OF ALLORECOGNITIONTransplantation, 1995
- Human endothelial stimulation of allogeneic T cells via a CTLA-4 independent pathwayTransplant Immunology, 1994
- Tolerance, Danger and the Extended FamilyAnnual Review of Immunology, 1994
- INDUCTION OF TRANSPLANTATION TOLERANCE TO RAT CARDIAC ALLOGRAFTS BY INTRATHYMIC INOCULATION OF ALLOGENEIC SOLUBLE PEPTIDES1Transplantation, 1993
- Indirect T cell allorecognition: a cyclosporin A resistant pathway for T cell help for antibody production to donor MHC antigensTransplant Immunology, 1993
- Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.The Journal of Experimental Medicine, 1992
- Cognate interactions between helper T cells and B cellsImmunology Today, 1990
- Cellular interactions in the generation of cytolytic T lymphocyte responses Analysis of the helper T cell pathwayEuropean Journal of Immunology, 1981
- Estimates of histocompatibility differences between inbred mouse strainsImmunogenetics, 1978